HIGHLIGHTS
- who: Peiling Zhang from the Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Wuhan, Hubei, China have published the research: Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma, in the Journal: (JOURNAL) of January/31,/2022
- what: In the study , when treated with ASCT in tandem with CAR30 T-cell infusion, superior response and survival can be obtained, even in 5 patients with a SD/PD (83.3%) before transplantation, for whom ASCT alone can hardly provide durable . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.